Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDT and/or TESI for Chronic Lumbar Radiculopathy
NCT02951377Phase 1Terminated
- Sponsor
- University of Alberta
- Start
- Oct 2017
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of dexamethasone in lumbar radiculopathy and Sciatica (2 arms), sponsored by University of Alberta. Primary endpoints: Roland-Morris Disability Questionnaire at 3 months, Leg Pain Intensity Numeric Rating Scale at 3 months and 1 more. Started Oct 2017; status: terminated.
02
Drugs
dexamethasone
03
Conditions
lumbar radiculopathySciatica
Beyond the preview
Go deeper on NCT02951377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02951377.